Yang C, Wei Z, Shen X, Jia Y, Wu Q, Wei Y
World J Gastrointest Oncol. 2024; 16(12):4579-4596.
PMID: 39678799
PMC: 11577363.
DOI: 10.4251/wjgo.v16.i12.4579.
Zhang L, Zhang F, Ma Z, Jin J
J Zhejiang Univ Sci B. 2024; 25(8):672-685.
PMID: 39155780
PMC: 11337088.
DOI: 10.1631/jzus.B2300261.
Forna L, Bozomitu L, Lupu V, Lupu A, Trandafir L, Adam Raileanu A
J Clin Med. 2024; 13(14).
PMID: 39064318
PMC: 11278264.
DOI: 10.3390/jcm13144275.
Cure O, Kizilkaya B, Durak S, Ilkkilic K
Rev Assoc Med Bras (1992). 2024; 70(7):e20240091.
PMID: 39045935
PMC: 11262325.
DOI: 10.1590/1806-9282.20240091.
Cheng M, Xie L
Nucl Med Mol Imaging. 2024; 58(5):279-290.
PMID: 39036458
PMC: 11254891.
DOI: 10.1007/s13139-024-00849-2.
Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase.
Liu J, Yu Y, Zhao H, Guo L, Yang W, Yan Y
Eur J Med Res. 2024; 29(1):343.
PMID: 38902822
PMC: 11191257.
DOI: 10.1186/s40001-024-01942-0.
A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients.
Zhang C, Shu Z, Chen S, Peng J, Zhao Y, Dai X
Sci Rep. 2024; 14(1):12081.
PMID: 38802526
PMC: 11130122.
DOI: 10.1038/s41598-024-63095-8.
The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
Xiong Y, Wang Z, Liu J, Li K, Zhang Y
Microorganisms. 2024; 12(5).
PMID: 38792805
PMC: 11124523.
DOI: 10.3390/microorganisms12050976.
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients.
Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Zhang L
J Clin Transl Hepatol. 2024; 12(5):469-480.
PMID: 38779514
PMC: 11106352.
DOI: 10.14218/JCTH.2023.00417.
Evaluation of Tenofovir Disoproxil Fumarate Treatment in Patients with Chronic Hepatitis B.
Konya P, Demirturk N
Infect Dis Clin Microbiol. 2024; 4(1):47-54.
PMID: 38633545
PMC: 11022821.
DOI: 10.36519/idcm.2022.78.
Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania.
Pacurar D, Dinulescu A, Jugulete G, Pasarica A, Dijmarescu I
Life (Basel). 2024; 14(3).
PMID: 38541675
PMC: 10970939.
DOI: 10.3390/life14030348.
Risk Factors for Development of Cirrhosis in Chronic Viral Hepatitis B Patients Who Had Persistent Viral Suppression With Antiviral Therapy.
Maung S, Decharatanachart P, Treeprasertsuk S, Chaiteerakij R
J Clin Exp Hepatol. 2024; 14(4):101388.
PMID: 38523735
PMC: 10956063.
DOI: 10.1016/j.jceh.2024.101388.
The delta in management of HDV/HBV coinfection: Lessons from a case.
Bhagwat M, Reau N
Clin Liver Dis (Hoboken). 2024; 23(1):e0113.
PMID: 38487352
PMC: 10939591.
DOI: 10.1097/CLD.0000000000000113.
A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression .
You M, Chen F, Yu C, Chen Y, Wang Y, Liu X
Front Pharmacol. 2024; 14:1213726.
PMID: 38205373
PMC: 10777313.
DOI: 10.3389/fphar.2023.1213726.
Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania.
Grecu L, Sultana C, Pavel-Tanasa M, Ruta S, Chivu-Economescu M, Matei L
Microorganisms. 2023; 11(12).
PMID: 38138039
PMC: 10745361.
DOI: 10.3390/microorganisms11122895.
Performance Evaluation of the Roche Cobas 5800 HBV and HCV Tests: Comparison of the 200 and 500 μL Protocols.
Jeong S, Lee S, Cho E, Kim H, Lee Y, Kim J
Ann Lab Med. 2023; 44(3):253-261.
PMID: 38098301
PMC: 10813821.
DOI: 10.3343/alm.2023.0306.
Managing HBV and HCV Infection Pre- and Post-liver Transplant.
Kumar N, Choudhary N
J Clin Exp Hepatol. 2023; 14(2):101287.
PMID: 38076445
PMC: 10709521.
DOI: 10.1016/j.jceh.2023.09.008.
HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients.
Song G, Yang R, Jin Q, Liu J, Rao H, Feng B
BMC Gastroenterol. 2023; 23(1):381.
PMID: 37946120
PMC: 10634007.
DOI: 10.1186/s12876-023-03023-8.
Ethanol-Producing Is Enriched in Chronic Hepatitis B-Associated Gut Dysbiosis: A Case-Control Culturomics Study.
Wasfy R, Mbaye B, Borentain P, Alou M, Murillo Ruiz M, Caputo A
Microorganisms. 2023; 11(10).
PMID: 37894093
PMC: 10608849.
DOI: 10.3390/microorganisms11102437.
Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy.
Barone M, Iannone A, Mezzapesa M, Milella M, Di Gennaro F, Niro G
Pathogens. 2023; 12(10).
PMID: 37887714
PMC: 10609832.
DOI: 10.3390/pathogens12101198.
